You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 6, DECEMBER 1958 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (139)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Role of Hemodialysis (Artificial Kidney) in Acute Poisoning

GEORGE E. SCHREINER, M.D.

AMA Arch Intern Med. 1958;102(6):896-913.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The role of the artificial kidney in acute human poisoning may be considered in two distinct categories: (1) dialyzable poisons, wherein the rate of removal is critical to the welfare of the patient, and (2) nephrotoxic poisons, which produce damage to the kidneys and are not qualitatively different from other causes of acute renal insufficiency. In some instances, general toxicity may be produced from the poison itself, while in others it is a product of the uremic syndrome. It is the purpose of the present study to review eight years of experience with clinical dialyses in acute poisonings and to summarize related studies, with particular emphasis on the role of the artificial kidney in dialyzable poisons.

Dialyzable Poisons

The effective use of hemodialysis in any acute poisoning is based on the following assumptions:

  1. That the poison molecule can diffuse through cellophane from plasma water and has a reasonable removal rate,
. . . [Full Text PDF of this Article]


Author Affiliations

Washington, D. C.

From the Department of Medicine and the Renal Laboratory, Georgetown University School of Medicine.


Footnotes

Submitted for publication June 26, 1958.

The work of this Laboratory has been supported by grants from the Hartford Foundation, the Washington Heart Association, and the Georgetown Kidney Research Fund.

Read in the Symposium on the Clinical Application of the Artificial Kidney before the Section on Experimental Medicine and Therapeutics at the 107th Annual Meeting of the American Medical Association, San Francisco, June 26, 1958.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1958 American Medical Association. All Rights Reserved.